Traditional Chinese medicine preparation for curing benign prostatic hyperplasia

Abstract

The invention provides a traditional Chinese medicine preparation for curing benign prostatic hyperplasia. Active ingredients of the preparation are prepared from the following raw materials according to weight ratio: 10-15 of radix glehniae, 9-12 of caesalpinia, 10-15 of light red Tuckahoe, 10-15 of root of common peony, 3-6 of radix glycyrrhizae preparata, 10-20 of raw rehmannia, 5-10 of plantain seed, 10-15 of liriope, 3-10 of inula lineariifolia turcz, 6-15 of cortex lycii radicis, and 10-15 of grilled astragalus. The dosage form of the prepared medicine is one of oral liquid, capsule, troche, pill and powder. The preparation disclosed by the invention not only can be used for tonifying Qi, clearing away the heart-fire, circulating heart and kidney, smoothing kidney water, enhancing bladder systolic function, promoting reduced volume of prostate and effectively relieving bladder outlet obstruction symptoms, but also can be used for coordinating balanced action on human blood and physiological function of the five internal organs (a heart, a liver, a spleen, lungs and kidneys), conditioning qi activity and achieving the purposes of treating disease from the root; furthermore, the preparation has the advantages of being light in dosage, accurate in curative effect, short in treatment course, high in cure rate, low in operation curing probability, low in side effect, and the like.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a traditional Chinese medicine preparation for treating benign prostatic hyperplasia accompanied by lower urinary tract obstruction symptoms, which is suitable for treating senile benign prostatic hyperplasia. Background technique [0002] Prostatic hyperplasia is a special pathological change of prostatic stroma and / or glandular hyperplasia, leading to benign prostatic enlargement and bladder outlet obstruction. It mostly occurs in male patients over 50 years old, and is the most common cause of voiding disorders in middle-aged and elderly men. A common benign disease. In 1984, Berry et al. summarized 5 groups of autopsy reports from different countries and found that the incidence of histological benign prostatic hyperplasia gradually increased with age. The 50-59 age group is about 40%, the 60-69 age group is about 70%, the 70-79 age group is about 80%, and the 80...

AI Technical Summary

Problems solved by technology

3. However, when the effect of drug treatment is not good, and the lower urinary tract symptoms have obviously affected the quality of life of the patient, surgical treatment should be considered